Loading organizations...
Loading organizations...
Biopharmaceutical company developing host-targeted anti-viral therapies.
Ansun BioPharma has raised $92.9M across 2 funding rounds.
Ansun BioPharma has raised $92.9M in total across 2 funding rounds.
Ansun BioPharma has raised $92.9M in total across 2 funding rounds.
Ansun BioPharma's investors include Junson Capital, Korea Investment Partners, Oceanpine Capital, Lilly Asia Ventures, Sinopharm Capital, 3E Bioventures Capital, Joincap Investment, LYFE Capital, Matrix Partners China, VI Ventures, YuanMing Capital.
Ansun BioPharma has raised $92.9M across 2 funding rounds. Most recently, it raised $7.9M Series B in October 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 15, 2019 | $7.9M Series B | Junson Capital, Korea Investment Partners, Oceanpine Capital | |
| May 14, 2018 | $85.0M Series A | Lilly Asia Ventures, Sinopharm Capital | 3E Bioventures Capital, Joincap Investment, LYFE Capital, Matrix Partners China, Oceanpine Capital, VI Ventures, YuanMing Capital |